Depleted uranium (DU) is a dense heavy metal used primarily in military applications. Although the health effects of occupational uranium exposure are well known, limited data enxst rding the long-term health effects of internaized DU in humans. We established an in viuro cellular model to study DU exposure. Microdosimetric assessment, determined using a Monte Carlo computer simulation based on measured intracelular and etacelular u m levels, showed that few (0.0014%) cell nuldei were hit by alph partidles. We report the ability of DU-uranyl chloride to tansform immortalized human osteoblastic cells (HOS) to the tumoriWnic phenotype. DU-uranyl chloride-transformants are characterized by anchorage-independent growth, tumor formation in nude mice, expression of high levels of the k-ras oncogene, reduced production of the Rb tumorsuppressor protein, and elevated levels of sister chromatid nges per cell. DU-uranyl 
, DU is a low specific-activity heavy metal, with a density approximately 1.7 times that of lead (19 g/cm3 versus 11.35 g/cm3). DU differs from natural uranium in that it has been depleted of 235U and 234U. As a result, the specific activity of DU is significantly lower than that of natural uranium (0.4 pCi/g versus 0.7 pCi/g, respectively) (2).
Assessment of the carcinogenic risks from DU is complicated by the dual toxicity of uranium (i.e., chemical as well as radiological). Epidemiological studies have linked uranium mining and milling to human carcinogenesis (1) , but there are no published studies to permit an accurate assessment of risks for carcinogenesis from DU. The radiological health risks (external exposure) to personnel handling DU munitions were evaluated and determined to be within allowed occupational exposure limits (1, 2) ; the health risks from internalized DU, however, are more difficult to estimate due to the physical and chemical properties of the internalized DU (3). The chemical toxicity of acute, short-term exposures to uranium, primarily manifested as renal, pulmonary, and developmental toxicity, has clearly been demonstrated in animals and humans (4) . In contrast, the long-term health risks associated with internal chronic exposure are not as dearly defined (1) . In view of carcinogenesis risk estimates and medical management questions relevant to current and possible future incidents of DU internalization, an examination of molecular and cellular effects, induding the potential transforming ability of DU, are necessary to understanding the potential carcinogenic effects of DU. The use of cell culture models to investigate potential or known carcinogens can provide important insights into the cellular and molecular mechanisms of carcinogenesis.
In spite of epidemiological studies that suggest that uranium is a carcinogen (1), there is no evidence that uranium ofany type (depleted, naturally occurring, or enriched) can transform human cells to the tumorigenic phenotype (1) . Furthermore, the in vitro transformation assay has not previously been used to study the transforming ability of any uranium compounds (depleted, naturally occurring, or enriched uranium). This assay has been widely used in conjunction with metal salts to assess the potential carcinogenicity of metal compounds (e.g., nickel, chromium, lead) (5-) and therefore we chose to use this assay to assess the potential carcinogenicity of DU. Investigations using metal salts have also been able to darify the contradictions observed in some animal and human carcinogenicity studies (8) . The HOS TE85 cell line, an immortalized, nontumorigenic osteoblastlike cell line, has been successftully used to demonstrate the transformation of nontumorigenic human cells to the tumorigenic phenotype by metals (7, 8) and chemical (9) We determined cell survival fraction (SF) using the conventional clonogenic assay (9) . Cytotoxicity and survival assays were conducted in parallel with each transformation assay as described (9 Sister chromatid analysis. The yield of sister chromatid exchange (SCE ) per cell in control and DU-UO22+ exposed cells following a 24-hr exposure was assessed in 100 second mitotic metaphase spreads (48-hr culture) using the conventional fluorescence-plus-Giemsa harlequin staining protocol (13) . The SCE yield in selected transformed clones was similarly determined.
Microdosimetry. The term "specific energy" is used rather than "dose" because dose refers to macroscopic averages, whereas specific energy is a microdosimetric equivalent (i.e., dose to a single cell). We applied microdosimetric methods using Monte Carlo computer simulations (14) . The code was modified to include the following parameters in the calculations: cell location and size, distribution of uranium (intracellular and extracellular), specific activity, alpha particle energies, media volume, and molar concentration of uranyl chloride. We calculated the trajectory of each alpha particle using vector analysis to determine whether it would hit a nucleus. For those that scored a hit, the amount of energy transferred to the nucleus was calculated by determining the residual energy retained by the alpha particle as it penetrated the nucleus and integrating the fractional energy loss under the Bragg curve from the entry point to the exit point. Kineticphosphorescence analysis ofuranium. Kinetic phosphorimetry measurements were performed using a kinetic phosphorescence analyzer (KPA) (15) . To determine the amount of uranium per cell following a 24-hr treatment with 10 p1M DU-UO22+, cells were treated and then rinsed in phosphate-buffered saline. Using previously described procedures, cells were lysed and fractionated into subcellular fractions. Lysates were analyzed for uranium content as described (15) .
Northern blot analysis and DNA probes. Cytoplasmic RNA was extracted from exponentially growing cells and separated by electrophoresis in 1% agarose-formaldehyde gels. RNA preparation and blotting onto nytran filters, hybridization with radiolabeled DNA probes, and autoradiography were as previously described (9). The ras probe, a Sac I 2.9 kb fragment of the human k-ras gene, was obtained from Oncor (Gaithersburg, MD). We prepared 32P-labeled DNA probes using a random primed DNA 40C . Processing ofimmunoprecipitates was as previously described (9) . The proteins were resolved on 7.5% polyacrylamide gels and analyzed by autoradiography.
Results
Characterization ofmodel system: cytotoxicity, SCE induction, and microdosimetry. We initially assessed the effect of DU-UO2CL2 exposure on cell growth and survival, cytogenetic damage, and microdosimetry to characterize our cell model system. No effect on cell survival (surviving fraction, SF, 0.96 ± 0.04) was observed using the standard colony formation assay (9) following a 24-hr exposure to DU-UO22+ (10 jiM). Growth rate analysis by cell enumeration and thymidine incorporation into DNA (9) To examine the stochastic fluctuations of alpha partide hits and energy deposition in the cell nudei, microdosimetric methods using Monte Carlo computer simulations were applied (Figure 1 B) . The computer code, designed by Humm (14) to predict cell inactivation by internal alpha emitters, was modified to correspond to the experimental conditions as described in Materials and Methods. The trajectory of each alpha partide was calculated using vector analysis to determine whether it would hit a nudeus. The energy transferred to the nucleus was calculated by determining the residual energy retained by the alpha partide as it penetrated the nucleus. The calculations determined that only 0.0014% of the nudei were hit and that the mean specific energy received by those cells was approximately 17 cGy. The results, plotted as a frequency distribution, are shown in Figure 1B .
Transformation ofHOS cells by DU-UO/2: comparison to NiSO4 and lead acetate. To assess for morphological cell transformation, the standard focus formation assay described by Reznikoffet al. (10) and Hill et al. (12) was used. After exposure to DU-UO22+, a morphological change in HOS cells was observed (Fig. 2) . HOS cells exhibit a flat epithelial-like morphology and appear to grow in a monolayer ( Fig. 2A) . In contrast, after treatment with DU-UO22+ and weekly changes of nutrient medium for 5 weeks, diffuse type II foci appeared (Fig.   2B ). The morphology of the focus is distinctly different from the surrounding cells (Fig. 2B) , although the focus does not exhibit the "piled up" appearance seen in transformed C3HlOT112 cells (10) . Table 1 shows measured values for the transformation frequencies (normalized per surviving cell) for HOS cells treated with DU-UO22+ (10 pIM). The Biological characterization ofthe transformed phenotype. Alteration in growth control is critical to neoplastic transformation, and therefore the metal-transformed clones were further characterized by quantitative differences in growth properties associated with the neoplastic phenotype (e.g, saturation density and soft colonyforming efficiency). Additionally, to determine if cells transformed in vitro were capable of producing tumors in immunosuppressed mice, the nude mouse assay was used to test the tumorigenicity of DUtransformed cells (9, 10) . From Table 2 it can be seen that the saturation densities of DU-transformed cells were three to four times higher than that of the parental HOS cells. Data obtained for NiSO4-and lead acetate-transformed cells were similar to that for DU. A comparison of the transformants' ability to grow in soft agar reveals that the DU transformants generated colonies within 1 week, with colony-forming efficiencies of 32-51%; the plating efficiencies were somewhat lower for NiSO4-or lead acetate-transformed cells. Parental HOS cells did not form colonies in soft agar ( Table 2) . We have previously shown that MNNG and EJ-ras transformants formed soft agar colonies whose size and frequency were comparable to those observed with these DU transformants (9) .
Inoculation of athymic nude mice with DU transformants resulted in the development of animal tumors within 4 (17) . Both metal-and radiation-induced neoplastic transformation have been shown to be associated with genetic alterations in specific oncogenes and tumor-suppressor proteins, such as ras and pRb (6, 9) . Therefore, possible molecular changes in ras and pRb associated with DU-induced transformation were studied using the four DU-transformed cell lines. Northern blot analysis, shown in Figure 3A, (Fig.  3B ). The lack of phosphorylation of pRb could be a result of less protein available to phosphorylate, abnormalities of the cyclinassociated kinase systems responsible for phosphorylation of pRb, a mutation in the Rb gene, or a combination of these possibilities. Previous observations with nickeltransformed HOS cells demonstrated a mutation was induced in these transformants that affected the ability of the Rb protein to be phosphorylated and function normally (6) .
Dose response: morphological transformation by UO2CI7 To further evaluate the ability of DU-uranyl chloride to morphologically transform cells, increasing concentrations of DU were tested for their transforming ability. The results in Table 3 show that there is a DU concentrationdependent increase in transformation frequency. A transformed clone was selected from each concentration tested and expanded to mass culture. An examination of the selected transformants' ability to grow in soft agar reveals that the DU transformants generated large colonies (>0.5 mm) within 1 week with colony-forming efficiencies ranging from 33% to 53%. Inoculation of athymic nude mice with these DU transformants resulted in the development of tumors within 4 weeks. 
Discussion
Our studies demonstrate for the first time that the malignant transformation of immortalized human cells can be achieved by exposure to the depleted uranium compound U02C12. These transformants showed morphological changes and anchorage-independent growth in soft agar, induced tumors when transplanted into nude mice, and exhibited alterations in ras oncogene expression and pRb phosphorylation. Based on equivalent concentrations and metal toxicities, the magnitude of this DU-UO2 2+ transformation is comparable to that seen here for NiSO4 and approximately twofold higher than that observed for lead acetate, both known transforming metals (8, 16 The precise mechanism(s) by which DU-UO22+ induces transformation in HOS cells is unknown. The possibility that alterations in specific oncogenes (e.g., ras) and/or inactivation of tumor-suppressor genes (e.g., p53, Rb) are involved in the conversion of these cells to the malignant phenotype has been considered. HOS cells contain a mutation at codon 156 resulting in a mutated form of p53 protein, which is believed to be partially responsible for their immortalization (18) . As neoplastic conversion is postulated to result from a multistep process involving cell immortalization and gene alterations (17, 19) , the transformation of immortalized HOS cells by DU- UO22+ to the malignant phenotype may involve other cellular oncogenes in this process. Our data demonstrate that the ras oncogene was activated in the transformation process induced by DU exposure. The ras oncogenes have been implicated in both chemically and radiation-induced animal tumors (20) (21) (22) and spontaneous human tumors (23) (16) . An elevation in SCE levels has also been observed as the result of inhibition of DNA replication, rather than by direct damage of chromosomes (25) . Our observation of an elevation in the level of SCE per cell, while consistent with these concepts, cannot distinguish between them. The mechanism of action at the genomic level for DU-induced transformation has not been determined and awaits further investigation; it is possible that DU induces transformation via mechanisms similar to those observed for nickel or lead, or by other by unknown mechanisms. Elucidation of the mechanism by which DU transforms cells is further complicated by the concurrent exposure to both the chemical (heavy metal) component and the radiological (alpha particle) components from DU. The chemical toxicity of uranium, based on animal and epidemiology studies, is well known (27) and is believed to be responsible for cytogenetic damage observed in the lymphocytes from men occupationally exposed to insoluble uranium (28) (30) .
DNA is an effective chelator of metal ions, which suggest the possibility ofa metal-mediated, site-specific free radical damage (31) .
Increased lung cancer risks in uranium miners and uranium milling workers have been attributed to exposure to the alpha partide emitter radon and its daughter products (1,32. In our study with DU exposures in vitro, the biological effect from the radiological component may be significantly reduced since so few cells (0.0014%) are actually hit by alpha-partide emissions (1 alpha partide traversal/cell hit). Therefore, in our study, the defining question is whether the alpha particle dose distribution and its track could effectively produce a change in that target cell that would induce or promote morphological transformation. Preliminary data using an alpha particle microbeam have demonstrated that one alpha particle traversal of a cell is not enough to induce morphological transformation (33) . Although these data from Miller's laboratory and our results argue for a negligible role for alpha radiation in the DU-UO22+-induced transformation, low levels of exposure to alpha radiation have been shown to induce genetic changes (34) and chromosomal instability (35) in the progeny of alpha-irradiated cells. The involvement of transmitted genetic instability in the transformation process is not fully understood and cannot be ignored because it could possibly be involved in the DU-UO22+-induced transformation.
Whether by radiation or chemical mechanism, DU-UO22+ exposure is consistent with the generally accepted features associated with neoplastic transformation of cells by radiation or metal exposure including formation of sister chromatid exchanges (31, 36, 37) and genomic instability manifested as gene alterations (6, 36, 38) .
In summary, we have used a model system of in vitro human osteoblast cells exposed for 24 hr to DU-uranyl chloride (10 FM), nickel sulfate (10 pM), or lead acetate (10 pM) to assess relative transforming potential of DU in an effort to better understand the potential health risks from long-term exposure to internalized DU. Despite the wellknown low solubility of uranyl compounds, we found cellular uptake of uranium consistent with other transuranic compounds (39 DU-U02+ appears to have transforming ability slightly greater than that of many other trace heavy metals, which also induce neoplastic cell transformation in vitro, as well as cause tumor formation in animals (40) . While additional animal studies are needed to address the effect of protracted exposure and tumor induction in vivo, the implication from our model system study is that the risk of neoplastic induction from internalized DU exposure may be similar to other biologically reactive and carcinogenic heavy metal compounds such as lead and nickel.
